Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neurodegenerative diseases.

¹University of Oxford, University Laboratory of Physiology, Parks Road, Oxford, OX1 3PT, UK. anthony.hannan@physiol.ox.ac.uk

Idrugs : the Investigational Drugs Journal

|July 22, 2005

Summary

This report highlights key pharmacological advancements for neurodegenerative diseases discussed at a major neuroscience meeting. It focuses on treatments and therapeutic strategies relevant to conditions like Alzheimer's and Parkinson's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Attenuated responses to attention-modulating drugs in the neuroligin-3<sup>R451C</sup> mouse model of autism.

Journal of neurochemistry·2024

Same author

Chronically high stress hormone levels dysregulate sperm long noncoding RNAs and their embryonic microinjection alters development and affective behaviours.

Molecular psychiatry·2023

Same author

Assessing attention orienting in mice: a novel touchscreen adaptation of the Posner-style cueing task.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2020

Same author

Limitations to intergenerational inheritance: subchronic paternal stress preconception does not influence offspring anxiety.

Scientific reports·2020

Same author

Environmental enrichment modulates affiliative and aggressive social behaviour in the neuroligin-3 R451C mouse model of autism spectrum disorder.

Pharmacology, biochemistry, and behavior·2020

Same author

Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide.

NPJ schizophrenia·2017

Area of Science:

Neuroscience
Pharmacology
Neurodegenerative Diseases

Background:

The millennium neuroscience meeting covered diverse topics.
This report specifically addresses pharmacological developments.
Focus is on neurodegenerative disease relevance.

Purpose of the Study:

To summarize pharmacological advancements in neurodegenerative diseases.
To identify key therapeutic developments from the meeting.

Main Methods:

Review of presentations from a large neuroscience conference.
Selection of content focused on pharmacology.
Filtering for relevance to neurodegenerative diseases.

Main Results:

Identification of emerging pharmacological strategies.
Overview of novel drug developments.
Discussion of therapeutic targets for neurodegenerative conditions.

Conclusions:

Pharmacological research is crucial for neurodegenerative disease treatment.
The reviewed developments offer potential therapeutic avenues.
Continued focus on drug discovery is essential for neurological disorders.

Related Experiment Videos